OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2021
(3)
2023
(2)
2025
(1)
2022
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Not available
S-EPMC10390421
|
biostudies-literature
Cite
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.
Not available
S-EPMC11701305
|
biostudies-literature
Cite
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity.
Not available
S-EPMC8310844
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Not available
S-EPMC7646625
|
biostudies-literature
Cite
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Not available
S-EPMC8314785
|
biostudies-literature
Cite
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Not available
S-EPMC9259496
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets